Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, announced today that its common stock will be added to the MSCI USA Small Cap Index effective Tuesday, November 30th at the close of market. The MSCI USA Small Cap Index is designed to measure the performance of the small cap segment of the U.S. equity market. With 1,851 constituents, the index represents approximately 14% of the free float-adjusted market capitalization in the U.S. Key exposures of risk and return in the index include small capitalization, value, and momentum, with 14% of the index in healthcare.
https://www.biospace.com/article/releases/oramed-to-join-msci-usa-small-cap-index/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.